Previous 10 | Next 10 |
2023-11-08 16:42:10 ET MaxCyte press release ( NASDAQ: MXCT ): Q3 GAAP EPS of -$0.11 misses by $0.01 . Revenue of $8M (-24.5% Y/Y) misses by $0.11M . Continue to expect to end the year with approximately $200 million in cash, cash equivalents and investments. ...
ROCKVILLE, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproce...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
MaxCyte Inc. (MXCT) is expected to report $-0.09 for Q3 2023
ROCKVILLE, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproce...
2023-10-18 17:39:01 ET Gainers: Netflix ( NFLX ) +12% . Melco Resorts & Entertainment ( MLCO ) +5% . ADTRAN Holdings ( ADTN ) +4% . Acumen Pharmaceuticals ( ABOS ) +4% . Gracell Biotechnologies ( GRCL ) +4% . ...
2023-10-09 16:06:08 ET Penny Stocks: Using Analyst Sentiment and Research for Smart Trading Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk. Thorough research is essential before trad...
2023-10-05 12:59:42 ET More on Grupo Aeroportuario del Centro Norte, Grupo Aeroportuario del Pacifico, etc. For further details see: BTWN, OMAB and PAC among mid-day movers
2023-10-05 10:00:20 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Citi turns cautious on pharmaceuticals and biotech For further details see: Orchard Therapeutics, Longeveron among healthcare movers
2023-10-05 08:16:47 ET More on BioXcel Therapeutics, Lithium Americas Corp., etc. Lithium Americas (Argentina): An Outrageously Undervalued Lithium Company BioXcel: Navigating The Peaks And Valleys Of Regulatory Uncertainties BioXcel's Struggles: From FDA Issues To F...
News, Short Squeeze, Breakout and More Instantly...
ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bio...
ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc . , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and inn...
ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and innovative bioproce...